Search clinical trials for: SEN0014196

Total 5 results

Siena Biotech S.p.A.
Seventh Framework Programme; European Huntington's Disease Network

Completed

An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196 (PADDINGTON)

Huntington Disease

Germany
Siena Biotech S.p.A.

Completed

A Phase II Safety and Tolerability Study With SEN0014196

Huntington's Disease

Germany
Siena Biotech S.p.A.

Completed

Escalating Dose Study in Healthy Volunteers With SEN0014196

Huntington's Disease

United Kingdom
Wake Forest University Health Sciences

Withdrawn

SIRT-1 Antagonism for Endometrial Receptivity (SAFER)

Uterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, Nonimplantation

United States
Siena Biotech S.p.A.

Completed

A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease

Huntington's Disease

United States

3

Subscribe